NYSE:EBS | Buybacks | Emergent BioSolutions Inc.

EBS Buybacks

21 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–21; provenance stays internal.

Issuer profilePeriod endTypeReported cash
Emergent BioSolutions Inc.2026-03-31Reported repurchase cash$9M
Emergent BioSolutions Inc.2025-12-31Reported repurchase cash$9.1M
Emergent BioSolutions Inc.2025-03-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2024-12-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2023-12-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2023-03-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2022-12-31Reported repurchase cash$200,000.00
Emergent BioSolutions Inc.2022-03-31Reported repurchase cash$57.5M
Emergent BioSolutions Inc.2021-12-31Reported repurchase cash$106M
Emergent BioSolutions Inc.2021-03-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2019-12-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2019-03-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2018-12-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2018-03-31Reported repurchase cash$100,000.00
Emergent BioSolutions Inc.2017-12-31Reported repurchase cash$33.02M
Emergent BioSolutions Inc.2017-03-31Reported repurchase cash$81,000.00
Emergent BioSolutions Inc.2016-12-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2016-03-31Reported repurchase cash$0.00
Emergent BioSolutions Inc.2013-12-31Reported repurchase cash$213,000.00
Emergent BioSolutions Inc.2012-12-31Reported repurchase cash$4.45M
Emergent BioSolutions Inc.2011-12-31Reported repurchase cash$0.00